These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Changes in serum cortisol levels during community-acquired pneumonia: the influence of dexamethasone. Remmelts HH; Meijvis SC; Kovaleva A; Biesma DH; Rijkers GT; Heijligenberg R Respir Med; 2012 Jun; 106(6):905-8. PubMed ID: 22402329 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and significance of various scores for pneumonia severity in the management of patients with community-acquired pneumonia in China. Yang Y; Xu F; Shi LY; Diao R; Cheng YS; Chen XY; Jing JY; Wang XD; Shen HH Chin Med J (Engl); 2012 Feb; 125(4):639-45. PubMed ID: 22490488 [TBL] [Abstract][Full Text] [Related]
4. Systemic and bronchoalveolar cytokines as predictors of in-hospital mortality in severe community-acquired pneumonia. Lee YL; Chen W; Chen LY; Chen CH; Lin YC; Liang SJ; Shih CM J Crit Care; 2010 Mar; 25(1):176.e7-13. PubMed ID: 19592208 [TBL] [Abstract][Full Text] [Related]
6. Inhaled corticosteroids and systemic inflammatory response in community-acquired pneumonia: a prospective clinical study. Ferrer M; Torres A; Martínez R; Ramírez P; Polverino E; Montull B; Sialer S; Niederman MS; Agusti A; Menéndez R Respirology; 2014 Aug; 19(6):929-35. PubMed ID: 24909304 [TBL] [Abstract][Full Text] [Related]
7. Circulating cytokines as markers of systemic inflammatory response in severe community-acquired pneumonia. Igonin AA; Armstrong VW; Shipkova M; Lazareva NB; Kukes VG; Oellerich M Clin Biochem; 2004 Mar; 37(3):204-9. PubMed ID: 14972642 [TBL] [Abstract][Full Text] [Related]
8. [Influence of systemic corticosteroid administration in the prognosis of patients with community-acquired pneumonia]. Fernández-Herranz J; de Miguel-Díez J; Del Castillo-Rueda A; Bellón-Cano JM; Jiménez-García R; Alvarez-Sala-Walther LA Rev Clin Esp; 2012 Jul; 212(7):337-43. PubMed ID: 22621712 [TBL] [Abstract][Full Text] [Related]
9. Systemic corticosteroids for community-acquired pneumonia: reasons for use and lack of benefit on outcome. Polverino E; Cillóniz C; Dambrava P; Gabarrús A; Ferrer M; Agustí C; Prina E; Montull B; Menendez R; Niederman MS; Torres A Respirology; 2013 Feb; 18(2):263-71. PubMed ID: 23134361 [TBL] [Abstract][Full Text] [Related]
10. [Prolonged infusion of hydrocortisone in patients with severe community acquired pneumonia]. Confalonieri M; Trevisan R Recenti Prog Med; 2006 Jan; 97(1):32-6. PubMed ID: 16535928 [TBL] [Abstract][Full Text] [Related]
11. [The influence of community-acquired pneumonia to the clinical course in COPD cases admitted to intensive care unit with acute respiratory failure]. Güngör G; Yazıcıoğlu Moçin O; Acartürk E; Başbuğ Y; Saltürk C; Yalçınsoy M; Karakurt Z Tuberk Toraks; 2010; 58(4):408-17. PubMed ID: 21341118 [TBL] [Abstract][Full Text] [Related]
12. Albumin and C-reactive protein have prognostic significance in patients with community-acquired pneumonia. Lee JH; Kim J; Kim K; Jo YH; Rhee J; Kim TY; Na SH; Hwang SS J Crit Care; 2011 Jun; 26(3):287-94. PubMed ID: 21129911 [TBL] [Abstract][Full Text] [Related]
13. Improving outcomes in elderly patients with community-acquired pneumonia by adhering to national guidelines: Community-Acquired Pneumonia Organization International cohort study results. Arnold FW; LaJoie AS; Brock GN; Peyrani P; Rello J; Menéndez R; Lopardo G; Torres A; Rossi P; Ramirez JA; Arch Intern Med; 2009 Sep; 169(16):1515-24. PubMed ID: 19752410 [TBL] [Abstract][Full Text] [Related]
14. Severe community-acquired pneumonia: validation of the Infectious Diseases Society of America/American Thoracic Society guidelines to predict an intensive care unit admission. Liapikou A; Ferrer M; Polverino E; Balasso V; Esperatti M; Piñer R; Mensa J; Luque N; Ewig S; Menendez R; Niederman MS; Torres A Clin Infect Dis; 2009 Feb; 48(4):377-85. PubMed ID: 19140759 [TBL] [Abstract][Full Text] [Related]
15. Cytokines and Cortisol - predictors of treatment response to corticosteroids in community-acquired pneumonia? Urwyler SA; Blum CA; Coslovsky M; Mueller B; Schuetz P; Christ-Crain M J Intern Med; 2019 Jul; 286(1):75-87. PubMed ID: 30873676 [TBL] [Abstract][Full Text] [Related]
16. Effect of dexamethasone on respiratory syncytial virus-induced lung inflammation in children: results of a randomized, placebo controlled clinical trial. Somers CC; Ahmad N; Mejias A; Buckingham SC; Carubelli C; Katz K; Leos N; Gomez AM; DeVincenzo JP; Ramilo O; Jafri HS Pediatr Allergy Immunol; 2009 Aug; 20(5):477-85. PubMed ID: 19397752 [TBL] [Abstract][Full Text] [Related]
17. Biomarkers to guide the use of corticosteroids in community-acquired pneumonia: a wish rather than a tangible concept. Salluh JI; Povoa P J Infect; 2013 Mar; 66(3):290. PubMed ID: 23068451 [No Abstract] [Full Text] [Related]
18. The effect of age on the systemic inflammatory response in patients with community-acquired pneumonia. van Vught LA; Endeman H; Meijvis SC; Zwinderman AH; Scicluna BP; Biesma DH; van der Poll T Clin Microbiol Infect; 2014 Nov; 20(11):1183-8. PubMed ID: 24930498 [TBL] [Abstract][Full Text] [Related]
19. Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial. Torres A; Sibila O; Ferrer M; Polverino E; Menendez R; Mensa J; Gabarrús A; Sellarés J; Restrepo MI; Anzueto A; Niederman MS; Agustí C JAMA; 2015 Feb; 313(7):677-86. PubMed ID: 25688779 [TBL] [Abstract][Full Text] [Related]
20. Azithromycin monotherapy for patients hospitalized with community-acquired pneumonia: a 31/2-year experience from a veterans affairs hospital. Feldman RB; Rhew DC; Wong JY; Charles RA; Goetz MB; Arch Intern Med; 2003 Jul; 163(14):1718-26. PubMed ID: 12885688 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]